Source: Annual Congress 2013 –Basic research on lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
C. Fischer, K. Leithner, C. Wohlkoenig, E. Stacher, A. Olschewski, H. Olschewski, A. Hrzenjak (Graz, Austria). Histone deacetylase inhibitor panobinostat reduces hypoxia-related cisplatin resistance in NSCLC cells by HDAC-mediated Hifalpha destabilization. Eur Respir J 2013; 42: Suppl. 57, 3105

Member's Comments

No comment yet.

Related content which might interest you: Comparison of anticancer effects of a novel histone deacetylase (HDAC) inhibitor CG200745 and SAHA in non-small lung cancer cells Source: International Congress 2019 – Diagnostic procedures and biology of lung cancer Year: 2019 SMYD3 links lysine methylation of MAP3K2 to ras-driven lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Possible role of nuclear receptor nr4a1 in hypoxia-induced cisplatin resistance Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Histone demethylation and acetylation are involved in the epigenetic regulation of epithelial-mesenchymal transition (EMT) Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells Source: International Congress 2016 – Late-breaking translational research in lung cancer Year: 2016 Simvastatin overcomes gefitinib resistance in non-small cell lung cancer with the T790M mutation of epidermal growth factor receptor via Akt/b-catenin signaling dependent down-regulation of survivin Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Glucocorticoid reduces pemetrexed sensitivity by mediating senescence-associated secretory phenotype in Bcl-2 dependent manner in non-small-cell lung cancer Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Histone deacetylase inhibition significantly augments human mesothelioma cellular response to chemotherapeutic agents Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012 The role of HIF-1 pathway in non-small-cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Met amplification induces an aggressive phenotype in EGFR tyrosine kinase inhibitors resistant non-small-cell lung cancer Source: International Congress 2015 – New frontiers in biomedical research on thoracic tumours Year: 2015 Dihydroartemisinin combined with cisplatinum induced apoptosis and related mechanism research in human lung adenocarcinoma H1299 cells Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Shikonin-induced necroptosis is enhanced by the inhibition of autophagy in non-small cell lung cancer cells Source: International Congress 2016 – Basic science and case reports in lung cancer Year: 2016 Cox-2 inhibitors in the treatment of small cell lung cancer patients Source: International Congress 2015 – Advances in the therapy of lung cancer Year: 2015 Investigate which PKC isoform play an important role in human lung cancer cells against TRAIL-induced apoptosis Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer Source: ERS Lung Science Conference 2017 Year: 2017 LSC - 2017 - Re-education of tumor-associated macrophages by modulating histone deacetylases in lung cancer Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013 TRAP1 downregulation could overcome gefitinib resistance in NSCLC via EMT reversal Source: International Congress 2018 – Lung cancer: novel molecular markers and mechanisms Year: 2018 Valproate–doxorubicin: promising therapy for progressing mesothelioma. A phase II study Source: Eur Respir J 2011; 37: 129-135 Year: 2011